1 Product identity
Ingredient risk
1 ingredient to use with caution

Mito NT

BrandHoltraCeuticalsOther Combinations Capsule 14 ingredients 1 caution DSLD #19694
Net contents: 180 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-03-25
2 Ingredients (14)
IngredientGroupSafety
Vitamin EVitamin EConditionally Safe
CalciumCalciumConditionally Safe
PhosphorusPhosphorusGenerally Safe
MagnesiumMagnesiumUse with Caution
Alpha-Ketoglutaric AcidAlpha-Ketoglutarate
L-Carnitine L-TartrateL-CarnitineGenerally Safe
L-TyrosineTyrosine
PantethinePantethine
Proprietary NT BlendProprietary Blend (Combination)
Microcrystalline CelluloseCellulose
Croscarmellose SodiumCroscarmellose Sodium
Methyl CelluloseMethyl cellulose
Vegetable Magnesium StearateMagnesium stearateUse with Caution
SilicaSiliconGenerally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Vitamin E — Conditionally Safe
⚠ Increased bleeding risk
⚠ All-cause mortality at >400 IU/day
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Phosphorus — Generally Safe
⚠ Excess impairs calcium absorption
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
L-Carnitine — Generally Safe
⚠ Fishy body odor
⚠ TMAO concern
L-Tyrosine — Limited Evidence
⚠ May worsen hyperthyroidism
⚠ Migraine trigger in some
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID19694
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-03-25
6 More from HoltraCeuticals
View HoltraCeuticals Safety Scorecard → 48 products
Adrenal BoostAdrenal-CalmAge WellAloe 450Antiox MaxAntiox Max
7 Cite this page
Vancouver
Pkhakadze G. Mito NT — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 29]. Available from: https://supplement.ge/products/mito-nt-19694/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network